What is the share price of Indraprastha Medical Corporation Ltd (INDRAMEDCO) today?
The share price of INDRAMEDCO as on 5th December 2025 is ₹483.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
The past returns of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share are- Past 1 week: -4.41%
- Past 1 month: -14.64%
- Past 3 months: 0.96%
- Past 6 months: 12.65%
- Past 1 year: -2.63%
- Past 3 years: 475.12%
- Past 5 years: 819.33%
What are the peers or stocks similar to Indraprastha Medical Corporation Ltd (INDRAMEDCO)?
The peers or stocks similar to Indraprastha Medical Corporation Ltd (INDRAMEDCO) include:What is the dividend yield % of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
The current dividend yield of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is 0.91.What is the market cap of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹4513.06 Cr as of 5th December 2025.What is the 52 week high and low of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
The 52-week high of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹640.85 and the 52-week low is ₹307.25.What is the PE and PB ratio of Indraprastha Medical Corporation Ltd (INDRAMEDCO) stock?
The P/E (price-to-earnings) ratio of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is 28.03. The P/B (price-to-book) ratio is 7.56.Which sector does Indraprastha Medical Corporation Ltd (INDRAMEDCO) belong to?
Indraprastha Medical Corporation Ltd (INDRAMEDCO) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Indraprastha Medical Corporation Ltd (INDRAMEDCO) shares?
You can directly buy Indraprastha Medical Corporation Ltd (INDRAMEDCO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Indraprastha Medical Corporation Ltd
INDRAMEDCO Share Price
483.401.81% (-8.90)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
INDRAMEDCO Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
INDRAMEDCO Performance & Key Metrics
INDRAMEDCO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 25.83 | 7.56 | 0.91% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
INDRAMEDCO Company Profile
Indraprastha Medical Corporation Limited is engaged in healthcare business.
MAXHEALTH
PE Ratio
98.00
98.00
1Y Return
1.85%
1.85%
Buy Reco %
77.27
77.27
APOLLOHOSP
PE Ratio
71.61
71.61
1Y Return
0.43%
0.43%
Buy Reco %
86.21
86.21
FORTIS
PE Ratio
86.64
86.64
1Y Return
24.99%
24.99%
Buy Reco %
75.00
75.00
PE Ratio
49.80
49.80
1Y Return
47.18%
47.18%
Buy Reco %
77.78
77.78
ASTERDM
PE Ratio
6.28
6.28
1Y Return
34.87%
34.87%
Buy Reco %
100.00
100.00
INDRAMEDCO Forecast
INDRAMEDCO Forecasts
Price
Revenue
Earnings
INDRAMEDCO Share Price Forecast
INDRAMEDCO Share Price Forecast
2025
Current
₹492.30
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹492.30
Baseline
Forecast for Dec 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
INDRAMEDCO Company Revenue Forecast
INDRAMEDCO Company Revenue Forecast
2025
Current
₹1.38
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.38
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
INDRAMEDCO Stock EPS (Earnings Per Share) Forecast
INDRAMEDCO Stock EPS (Earnings Per Share) Forecast
2025
Current
₹17.56
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹17.56
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
INDRAMEDCO
INDRAMEDCO
Income
Balance Sheet
Cash Flow
Annual Normal View
INDRAMEDCO Income Statement
INDRAMEDCO Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 766.18 | 753.45 | 788.64 | 831.46 | 614.06 | 891.28 | 1,108.70 | 1,261.59 | 1,379.01 | 1,430.52 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,146.80 | ||||||||||
| Power & Fuel Cost | 20.91 | 19.26 | 19.70 | 21.16 | 17.18 | 20.56 | 22.74 | 26.01 | 27.09 | |||||||||||
| Employee Cost | 190.26 | 194.01 | 200.21 | 213.93 | 197.71 | 213.92 | 246.70 | 261.61 | 277.10 | |||||||||||
| Selling & Administrative Expenses | 76.58 | 72.29 | 78.20 | 83.66 | 186.62 | 292.12 | 407.26 | 462.43 | 494.81 | |||||||||||
| Operating & Other expenses | 399.17 | 394.31 | 409.28 | 425.63 | 171.60 | 247.26 | 271.27 | 301.29 | 313.09 | |||||||||||
EBITDA | 79.26 | 73.58 | 81.25 | 87.08 | 40.95 | 117.42 | 160.73 | 210.25 | 266.92 | 283.72 | ||||||||||
| Depreciation/Amortization | 30.53 | 30.68 | 29.75 | 32.97 | 33.32 | 34.94 | 39.27 | 40.08 | 44.33 | 43.16 | ||||||||||
| PBIT | 48.73 | 42.90 | 51.50 | 54.11 | 7.63 | 82.48 | 121.46 | 170.17 | 222.59 | 240.56 | ||||||||||
| Interest & Other Items | 7.91 | 8.90 | 6.87 | 5.92 | 3.34 | 3.41 | 4.28 | 4.06 | 6.27 | 6.14 | ||||||||||
| PBT | 40.82 | 34.00 | 44.63 | 48.19 | 4.29 | 79.07 | 117.18 | 166.11 | 216.32 | 234.42 | ||||||||||
| Taxes & Other Items | 14.57 | 12.90 | 16.21 | 4.57 | 1.96 | 20.45 | 31.03 | 42.15 | 55.33 | 59.68 | ||||||||||
| Net Income | 26.25 | 21.10 | 28.42 | 43.62 | 2.33 | 58.62 | 86.15 | 123.96 | 160.99 | 174.74 | ||||||||||
| EPS | 2.86 | 2.30 | 3.10 | 4.76 | 0.25 | 6.39 | 9.40 | 13.52 | 17.56 | 19.06 | ||||||||||
| DPS | 1.80 | 1.50 | 1.60 | 0.00 | 0.00 | 2.50 | 3.00 | 4.50 | 4.50 | 4.50 | ||||||||||
| Payout ratio | 0.63 | 0.65 | 0.52 | 0.00 | 0.00 | 0.39 | 0.32 | 0.33 | 0.26 | 0.24 |
INDRAMEDCO Company Updates
INDRAMEDCO Stock Peers
INDRAMEDCO Past Performance & Peer Comparison
INDRAMEDCO Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Indraprastha Medical Corporation Ltd | 28.03 | 7.56 | 0.91% |
| Max Healthcare Institute Ltd | 98.00 | 11.24 | 0.14% |
| Apollo Hospitals Enterprise Ltd | 71.61 | 9.33 | 0.18% |
| Fortis Healthcare Ltd | 86.64 | 7.32 | 0.11% |
INDRAMEDCO Stock Price Comparison
Compare INDRAMEDCO with any stock or ETFCompare INDRAMEDCO with any stock or ETF
INDRAMEDCO
INDRAMEDCO Holdings
INDRAMEDCO Shareholdings
INDRAMEDCO Promoter Holdings Trend
INDRAMEDCO Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
INDRAMEDCO Institutional Holdings Trend
INDRAMEDCO Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
INDRAMEDCO Shareholding Pattern
INDRAMEDCO Shareholding Pattern
INDRAMEDCO Shareholding History
INDRAMEDCO Shareholding History
Foreign Institutions
Mutual Funds Invested in INDRAMEDCO
Mutual Funds Invested in INDRAMEDCO
No mutual funds holding trends are available
Top 3 Mutual Funds holding Indraprastha Medical Corporation Ltd
| Funds (Top 3) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9699% | Percentage of the fund’s portfolio invested in the stock 0.14% | Change in the portfolio weight of the stock over the last 3 months -0.24% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 95/118 (-14) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0008% | Percentage of the fund’s portfolio invested in the stock 0.20% | Change in the portfolio weight of the stock over the last 3 months 0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 65/124 (-2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0002% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 709/1023 (-31) |
Compare 3-month MF holding change on Screener
smallcases containing INDRAMEDCO stock
smallcases containing INDRAMEDCO stock
Looks like this stock is not in any smallcase yet.
INDRAMEDCO Events
INDRAMEDCO Events
INDRAMEDCO Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
INDRAMEDCO Dividend Trend
No dividend trend available
INDRAMEDCO Upcoming Dividends
INDRAMEDCO Upcoming Dividends
No upcoming dividends are available
INDRAMEDCO Past Dividends
INDRAMEDCO Past Dividends
Cash Dividend
Ex DateEx DateSep 18, 2025
Final
Final | Div/Share: ₹4.50
Dividend/Share
₹4.50
Ex DateEx Date
Sep 18, 2025
Cash Dividend
Ex DateEx DateSep 13, 2024
Final
Final | Div/Share: ₹4.50
Dividend/Share
₹4.50
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateSep 15, 2023
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 15, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 15, 2022
Cash Dividend
Ex DateEx DateSep 12, 2019
Final
Final | Div/Share: ₹1.60
Dividend/Share
₹1.60
Ex DateEx Date
Sep 12, 2019
INDRAMEDCO Stock News & Opinions
INDRAMEDCO Stock News & Opinions
Articles & Videos
Earnings
Indraprastha Medical Corporation standalone net profit rises 16.65% in the September 2025 quarter
Net profit of Indraprastha Medical Corporation rose 16.65% to Rs 49.46 crore in the quarter ended September 2025 as against Rs 42.40 crore during the previous quarter ended September 2024. Sales rose 8.92% to Rs 381.03 crore in the quarter ended September 2025 as against Rs 349.82 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales381.03349.82 9 OPM %18.7218.19 - PBDT77.1768.10 13 PBT66.3156.93 16 NP49.4642.40 17 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to discuss results
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 1 November 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Indraprastha Medical Corporation Ltd leads gainers in 'A' group
Avalon Technologies Ltd, Shaily Engineering Plastics Ltd, RHI Magnesita India Ltd and Infibeam Avenues Ltd Partly Paidup are among the other gainers in the BSE's 'A' group today, 07 October 2025.Indraprastha Medical Corporation Ltd spiked 16.29% to Rs 556.1 at 11:47 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 3.87 lakh shares were traded on the counter so far as against the average daily volumes of 22676 shares in the past one month. Avalon Technologies Ltd surged 14.90% to Rs 1300. The stock was the second biggest gainer in 'A' group. On the BSE, 96894 shares were traded on the counter so far as against the average daily volumes of 47775 shares in the past one month. Shaily Engineering Plastics Ltd soared 12.98% to Rs 2431.15. The stock was the third biggest gainer in 'A' group. On the BSE, 13.89 lakh shares were traded on the counter so far as against the average daily volumes of 11851 shares in the past one month. RHI Magnesita India Ltd advanced 11.41% to Rs 490.35. The stock was the fourth biggest gainer in 'A' group. On the BSE, 10.75 lakh shares were traded on the counter so far as against the average daily volumes of 9780 shares in the past one month. Infibeam Avenues Ltd Partly Paidup gained 6.15% to Rs 11.4. The stock was the fifth biggest gainer in 'A' group. On the BSE, 1.61 lakh shares were traded on the counter so far as against the average daily volumes of 1.04 lakh shares in the past one month. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to convene AGM
Indraprastha Medical Corporation announced that the Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Indraprastha Medical Corporation standalone net profit rises 14.94% in the June 2025 quarter
Net profit of Indraprastha Medical Corporation rose 14.94% to Rs 51.46 crore in the quarter ended June 2025 as against Rs 44.77 crore during the previous quarter ended June 2024. Sales rose 4.94% to Rs 365.06 crore in the quarter ended June 2025 as against Rs 347.86 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales365.06347.86 5 OPM %20.0419.30 - PBDT78.4970.63 11 PBT68.3159.59 15 NP51.4644.77 15 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to conduct board meeting
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 6 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Indraprastha Medical Corporation announces cessation of director
Indraprastha Medical Corporation announced that Dr. Menaka Guruswamy (DIN 08742679) has completed her tenure viz. first term of five (5) consecutive years on 22 May 2025, as Independent Director on the Board of Directors of the Company. Owing to her professional commitments & law practice as a Senior Advocate at the Supreme Court of India, she has opted not to renew her second term as an Independent Director on the Board of Directors of the Company. Consequently, she cease to be the Independent Director of the CompanyPowered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Board of Indraprastha Medical Corporation recommends final dividend
Indraprastha Medical Corporation announced that the Board of Directors of the Company at its meeting held on 16 May 2025, inter alia, have recommended the final dividend of Rs 4.5 per equity Share (i.e. 45%) , subject to the approval of the shareholders.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Indraprastha Medical Corporation standalone net profit rises 31.57% in the March 2025 quarter
Net profit of Indraprastha Medical Corporation rose 31.57% to Rs 41.01 crore in the quarter ended March 2025 as against Rs 31.17 crore during the previous quarter ended March 2024. Sales rose 6.04% to Rs 333.75 crore in the quarter ended March 2025 as against Rs 314.73 crore during the previous quarter ended March 2024. For the full year,net profit rose 29.87% to Rs 160.99 crore in the year ended March 2025 as against Rs 123.96 crore during the previous year ended March 2024. Sales rose 8.97% to Rs 1356.36 crore in the year ended March 2025 as against Rs 1244.70 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales333.75314.73 6 1356.361244.70 9 OPM %18.3715.39 -18.0115.53 - PBDT66.1851.77 28 260.65206.19 26 PBT55.2741.56 33 216.32166.11 30 NP41.0131.17 32 160.99123.96 30 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to discuss results
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 16 May 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 10.65%, vs industry avg of 13.4%
Over the last 5 years, market share decreased from 2% to 1.73%
Over the last 5 years, net income has grown at a yearly rate of 29.84%, vs industry avg of 42.46%